Literature DB >> 18260046

Can early-onset nonoliguric hyperkalemia be predicted in extremely premature infants?

Sudhin Thayyil1, Stephen Terence Kempley, Ajay Sinha.   

Abstract

Hyperkalemia is common soon after birth in extremely premature infants and often occurs in the absence of oliguria or renal failure. Our objective was to examine the early biochemical indicators, clinical risk factors, and incidence of early-onset nonoliguric hyperkalemia in a cohort of extremely premature infants. We studied clinical and biochemical data from 154 consecutive premature infants < or = 28 weeks of gestation admitted to a tertiary neonatal unit over a 3-year period. Hyperkalemia (> 7 mmol/L) was found in 33 (21%) of patients during the first 4 days of life, with peak potassium levels occurring at 3 days of age. Hyperkalemic patients had similar birthweight, gestation, creatinine and sodium levels as normokalemic infants, but they had higher phosphate and urea levels, with lower calcium levels. The combination of a high phosphate (> 2.0 mmol/L) and a high potassium (> 5.6 mmol/L) within 6 hours of birth predicted later development of hyperkalemia, with a positive likelihood ratio of 8.3 (post-test probability, 70%). Potassium level of < 5.6 mmol/L at birth indicates subsequent hyperkalemia is unlikely (likelihood ratio, 0.25; post-test probability, 4%). Mildly elevated potassium and phosphate levels within 6 hours after birth may be useful in predicting the development of early-onset hyperkalemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18260046     DOI: 10.1055/s-2008-1040343

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

Review 1.  Regulation of Potassium Homeostasis.

Authors:  Biff F Palmer
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

2.  Nonoliguric hyperkalemia in a late preterm infant with severe birth asphyxia.

Authors:  Xiaoyu Xiong; Dan Chen; Jing Zhang; Jian Mao; Juan Li
Journal:  Transl Pediatr       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.